Major depressive disorder (MDD) is commonly observed in medical settings, with a prevalence of up to 14% compared with 2% to 4% in the general population.1 Various studies have found rates of 12% to 18% in patients with diabetes, 15% to 23% in those with coronary heart disease, 23% to 54% in patients with multiple…
The number of deaths by suicide in spring 2019 highlighted the ripple effects of violence and sparked reports that a phenomenon called “suicide contagion” may have been a contributing factor in these incidents.
Researchers found that there a many factors that contribute to nonadherence to antipsychotic medication in patients with schizophrenia, including the patient’s perception that the physician is in alliance with their family, rather than listening to what he or she wants. Physicians who were interviewed by Psychiatry Advisor recommend listening to what is important to the patient. Weight gain associated with medications might be unacceptable to some patients, or medication-induced somnolence, which to some could be intolerable, might help severe insomnia in others.
The epidemic of opioid use disorder has led to substantial increases in new cases of HCV and HIV infection, as well as hospitalizations for other OUD-related infections.
A range of studies show that connections among social identification, perception, and interpretation of social situations affect quality of life in patients with major depressive disorders.
An estimated 25% of children and adolescents report having pain that persists for more than 3 months, with severe and disabling pain affecting 8% of this population.
The integration of technology into medicine has expanded into various uses in patients with Parkinson disease.